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Background:  Primary bone tumour is a challenge to Orthopaedic surgeons working in developing 
countries due to late presentation as a result of ignorance and poverty. This is further compounded by 
limited number of specialist personnel, diagnostic and therapeutic centres. Consequently, they are 
associated with high rate of morbidity and mortality, which can be reduced with early presentation.
Materials and methods: This is a retrospective review of all histologically proven primary bone tumours 
seen at National Orthopaedic hospital Enugu,South east Nigeria, over a 6 year period. 
Results: Sixty eight (68) cases met the study criteria and were reviewed. Male:Female ratio was 1.35:1, 
with a mean age of 22.8years and peak frequency in the 11-20years age range.  A total of 28(41.1%) were 
benign, 21(30.9%) were malignant while 19(27.9%) were tumour-like conditions. The commonest 
benign tumour was osteochondroma, accounting for 44.7% of non-malignant lesions, while fibrous 
dysplasia was the commonest tumour-like condition(23.4%). Primary malignant bone tumours 
accounted for 30.9% of all  pathologies, with osteosarcoma(17) accounting for 80.1% of all malignant 
lesions. The commonest region affected is the leg i.e proximal tibia. Duration of symptoms before 
presentation ranged from 1month to 12years, with the commonest presenting complaint being a 
painless lump.  
Conclusion: Primary bone tumours is commonest in young males, usually benign and affecting the 
Tibia. Associated late presentation results in increased morbidity and mortality. Hence, efforts need to 
be geared towards public enlightenment in developing countries, to ensure early presentation, thereby 
reducing morbidity and mortality.
ABSTRACT
INTRODUCTION
proliferate to produce tumour-like lesions. As a result 
of this heterogenous nature, it is important to 
diagnose, stage and treat these tumours promptly. 
The actual aetiology of bone tumours is not known, 
1with many arising from somatic mutation  denovo. 
2Other factors implicated include irradiation , bone 
3 4infarcts , foreign bodies  and pre-existing bone lesions 
5like trauma . Benign tumours occur more commonly 
than primary malignancies, which are associated with 
high rate of morbidity and mortality especially with 
late presentation and inadequate management. Males 
nd rdare more affected than females, with 2  and 3  decades 
6-9of life being the peak age incidence.  In America, 
about 3000 new cases of bone tumours are seen 
10annually.  Primary bone tumour is a challenge to 







s a connective tissue, bone consists of many 
cell types including osteoblasts, osteoclasts, Areticular cells, supporting tissues like fibrous 
tissues, vessels and nerves and hematopoietic cells, all 
of which are incorporated into the matured bone. Any 
of these could proliferate into a tumour. There are 
basically two varieties of bone tumours- primary and 
secondary bone tumours. The primary tumours are 
further divided into benign and malignant tumours. 
In addition, the supporting structures could 
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countries, due to late presentation as a result 
of ignorance and poverty. The problem is 
further compounded by limited number of 
personnel, diagnostic and therapeutic centres.  
The precise incidence of bone tumours is not 
known in Nigeria, as majority of the 
diagnosed cases are not documented in the 
Nations cancer registry. Moreover many 
patients die without orthodox medical care 
and appropriate diagnosis. There are some 
studies in many parts of the country that has 
6-9brought to the fore these problems .This 
report is presenting our experience in a 
regional orthopaedic Hospital in Nigeria.
Sixty eight (68) case notes of histologically 
proven primary bone tumours and tumour-
like conditions were reviewed within the 6 
years under review (2001-2006). A total of 
28(41.1%) were benign, 21(30.9%) were 
malignant while 19(27.9%) were tumour-like 
conditions. Males were generally more 
affected in 39(57.3%) and a male to female 
ratio of 1.35:1. Of the benign tumours, 
15(53.6%) occurred in males and 13(46.4%) 
occurred in females, 12(57.1%) of the 
malignant tumours occurred in males and 
9(42.9%) in females while 12(63.2%) of the 
tumour-like conditions occured in males and 
7(36.8%) in females. 
The case notes of all patients who presented 
with histologically proven bone tumours at 
the National Orthopaedic Hospital Enugu 
from January - December 2001- 2006 were 
analysed. They were reviewed for age, gender, 
histological type of tumour, anatomical site 
of occurrence, duration of symptoms and 
clinical findings.  All secondary bone 
tumours, tumours of marrow origin which 
were referred to Hematologists and all case 
files with incomplete results were excluded 
from the study. 
MATERIALS AND METHODS 
RESULTS
TABLE 1: SEX DISTRIBUTION AND HISTOLOGICAL TYPES
HISTOLOGICAL TYPE MALE FEMALE TOTAL 
BENIGN    
OSTEOCHONDROMA 10 11 21 
OSTEOCLASTOMA 3 1 4 
OSTEOMA 2 - 2 
CHONDROMA - 1 1 
TOTAL 15 13 28 
    
MALIGNANT    
OSTEOSARCOMA 9 8 17 
CHONDROSARCOMA 2 1 3 
LARGE CELL 
LYMPHOMA 
1 - 1 
TOTAL 12 9 21 
    
TUMOR LIKE LESIONS    
FIBROUS DYSPLASIA 6 5 11 
OSSIFYING FIBROMA 1 1 2 
NON-OSSIFYING 
FIBROMA 
1 1 2 
SIMPLE BONE CYST 3 - 3 
HARMATOMA 1 - 1 
TOTAL 12 7 19 
    
GRAND TOTAL 39 29 68 
 
The age range was from 1 to 74 years with mean of 22.8yrs. 
Majority of the tumours 41(60%) occurred in patients aged 
20years and below with peak frequency in the 11-20 years 
age range. 
TABLE 2: AGE DISTRIBUTION ACCORDING TO HISTOLOGICAL TYPES
TYPE 1-
10YS 
11-20 21-30 31-40 41-50 51-60 61-70 71-80 UNSPECIFIED 
OSTEOCHONDROMA 1 14 4 1  1   1 
OSTEOMA     1  1   
CHONDROMA  1        
OSTEOCLASTOMA  1 1 2      
          
OSTEOSARCOMA 5 8 1 3      
CHONDROSARCOMA  2 1       
LARGE CELL 
LYMPHOMA 
       1  
          
FIBROUS DYSPLASIA 1 3 3 2   2   
OSSIFYING FIBROMA 1    1     
NON-OSSIFYING 
FIBROMA 
 1   1     
BONE CYST  3        
HARMATOMA   1       
TOTAL 8 33 11 8 3 1 3 1 1 
 
Among the benign bone tumours and tumour-like conditions, 
osteochondroma was by far the most common accounting for 
21(44.7%), followed by fibrous dysplasia 11(23.4%). Majority 
nd rdof these tumors occurred in the 2  and 3  decades of life. 
Osteosarcoma was the commonest malignant bone tumour 
accounting for 17(80.1%) of the malignant tumours. More 
st ndthan 80% 0f these tumours occurred in the 1  and 2  decades 
of life.
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The frequencies and pattern of histologically 
proven primary bone tumours was highlighted 
by this retrospective study at National 
Orthopaedic Hospital Enugu, a referral centre 
for Trauma and Orthopaedics in Enugu, 
Nigeria. This study found male preponderance 
which has been reported by other studies both 
6-9, 12, 19 within and outside Nigeria. The male to 
female ratio of 1.35:1 seen in our study is 
similar to the finding of Edinghton and 
11 6Maclean  in Ibadan, Odetayo  at National 
Orthopaedic Hospital Lagos(NOHL), Nigeria 
12and Rasahid et al  in China and slightly less 
than what was found in Zaria, Nigeria by 
7 8Mohammed et al  and Obalum et al  at Lagos 
University Teaching Hospital (LUTH),Nigeria. 
Our finding of peak age of occurrence of these 
tumours 11-20 years also agrees with the 
8study in LUTH . Majority (60%) of the tumours 
occurred in those 20 years or less, which was 
8slightly higher than 48% found in LUTH  and 
945% reported in Ibadan by Omololu et al  
among same age group. 
The preponderance of benign over malignant 
tumors had been highlighted by numerous 
6-9, 20studies.  The most common benign tumour 
was osteochondroma (44.7%) while  
Osteosarcoma was the most common 
malignant (80.1%) which is consistent with 
6-9, 21  results of several studies. Of the 
osteochondroma, 66% fell within the 11-20 
years age range similar to reports by 
7Mohammed et al  where it occurred most in late 
adolescence. The male to female ratio in our 
study was 1:1.1 which is different from the 
7reported ratio of 3:1 by Mohammed et al . The 
most common site of occurrence in our study 
was proximal tibia and fibula followed by other 
6long bones, similar to reports by Odetayo  in 
13Lagos and Kikum  and different from the site of 
7occurrence by Mohammed et al , where they 
found the face commonly affected. 
Giant cell tumor (Osteoclastoma) made up 
4(5.9%) of the total bone tumours with a male 
to female ratio of 3:1 which is different from 
7that found in Zaria by Mohammed et al  and 
The distal femur and proximal tibia accounted for majority of 
site of distribution of both the malignant and benign tumours. 
Sixteen (34%) of the benign and tumour-like conditions 
developed in the tibia and five(10.6%) occurred in the femur. 
Nine (19.1%) were seen on the face. There were 3 simple bone 
cyst, one occurred on the face while the rest occurred over the 
proximal left tibia. One case of chondromyxoid fibroma was 
diagnosed on the face while a harmatoma was excised from 
the lower lumbar vertebra which presented with low back 
pain. Of the malignant tumors 10(47.6%) occurred in the 
proximal tibia. Three cases of chondrosarcoma were diagnosed 
with 2 of them occurring in the iliac bone, the other in the left 
tibia.






















1 1 3 2 1  1 11 1 
CHONDROMA        1  
OSTEOMA    1    1  
OSTEOCLASTO
MA 
       4  
          
OSTEOSARCO
MA 
1  4    3 9  
CHONDROSAR
COMA 
    2   1  
LARGE CELL 
LYMPHOMA 
  1       
          
FIBROUS 
DYSPLASIA 




2         
OSSIFYING 
FIBROMA 
2         
SIMPLE BONE 
CYST 
1      2   
HARMATOMA      1    
          
TOTAL 14 1 8 3 3 1 10 27 1 
 
The duration of symptoms before presentation ranged from 1 
month to 12 years. One patient presented within two hours of 
sustaining a pathological fracture of left mid femur without 
initial symptoms. Majority of the malignant tumours 
presented earlier than benign tumours, usually before 4 years 
of onset of symptoms but typically within the first year of 
symptoms. The commonest presenting complaints include- 
swelling in 42 patients, which were commoner with the 
benign and tumour-like conditions; pain and swelling was 
observed in 20 patients, while only pain occurred in 5 patients. 
There were associated loss of function and deformity in 6 and 2 
patients respectively. 7 patients presented with pathological 
fractures while 3 patients each presented with proptosis, 
lymph node enlargement and neurological impairment. 
DISCUSSION
49
Nigerian Journal of Medicine, Vol. 23  No.1,   January-March, 2014,  ISSN 1115-2613
17also another study by Lawrence et al  where they 
found female preponderance. However there is no 
variation in the age patient at presentation, as 
seventy-five percent of these occurred in 20-50 age 
range. This is similar to the observation that these 
tumours rarely occurred in those less than 20 and 
6,7above 55 years age range .
The prevalence of Osteosarcoma as the most common 
primary bone tumour has been reported by several 
studies and corroborated by this study. The ratio of 
male to female is 1.1:1 with peak age range incidence 
in the second decade of life is in agreement with other 
6,7studies . 
  Majority of these tumours occurred around the knees 
with 9 on the proximal tibia and fibula and 3 on distal 
femur. The proximal humerus followed next in 4 
patients. These findings were equally reported by 
6 14Odetayo  in Lagos and Klien et al  but different from 
7the reports of Mohammed et al , where they had more 
rdfemale preponderance, peak age incidence in 3  decade 
and the face as the commonest site affected. Ayala et 
18al  also found high female to male ratio but the 
commoner site was still the long bones.  The common 
occurrence of chondrosarcoma in the pelvic bone and 
its higher prevalence in the male, has equally been 
6-9reported by other studies . In a large series, Kissane et 
15al  found a male to female ratio of 1.5:1; highest age 
frequency of 10 - 15 years which is similar to our 
findings of male to female ratio of 2:1 and age 
majority in 11-20 age range. However the long bones 
16were more affected in their series. In the Bernes et al  
series, the pelvis, femur, ribs and shoulder girdle were 
7more affected. In Zaria, Mohammed et al  found the 
rdface to be more affected and 3  decade the commonest 
age range. 
Most of the tumour-like lesions were fibrous dysplasia 
11(57.3%) with a slight male preponderance. Majority 
of the patients (63.6%) were less than 30 years old. 
7Mohammed et al  observed similar parameters in 
Zaria with a variation in the sex distribution where in 
their study, there is slight female preponderance. 
The duration and presentation of these patients 
reported in this study was similar to findings by 
Odetayo in National Orthopaedic Hospital Lagos, 
though all the patients in this study presented within 
12 years of onset of symptoms. He equally reported 
that swelling was the commonest complaint in his 
own series, however some of the patients in his series 
presented up to 24 years from onset of symptoms. We 
also observed that all the malignant tumours 
presented with pain and may account for their relative 
earlier presentation in all within 4 years, with 
majority (75%) presenting within 1 year as against 
benign tumours in which most of the patients 
presented after 1 year of onset of symptoms. 
From our study, 7 patients had pathological fracture, 
5 of whom had fibrous dysplasia and 1 of them 
presenting within 2 hours of sustaining the fracture 
following a fall, without initial symptoms. The other 
2 had Osteosarcoma. 3 patients had features of chest 
metastases with respiratory distress and cannon ball 
lesions on X-rays while 2 had neurological 
impairment of foot drop due to the site of the tumor in 
proximal fibula and paraplegia in a patient with intra-
spinal extension of a harmatoma involving a vertebra. 
Primary bone tumours are commoner in males, with a 
peak age group of 11 – 20 years, usually not 
malignant but usually presents late. Early recognition 
and prompt treatment is necessary to reduce 
morbidity from primary bone tumours. Public 
enlightenment campaigns on the need to present early 
to the appropriate hospital, even when a lump is 
painless, will help in establishing diagnosis and 
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